New products
Abbott rolls out SimpleScreen CRC blood test across US
Abbott has commercially launched SimpleScreen CRC, an FDA-approved blood test for colorectal cancer screening, across the United States. The test represents a non-invasive screening option in the colorectal cancer detection market.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network